Clinical Trial Update: Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 trial update on neoadjuvant therapy for resectable intrahepatic cholangiocarcinoma with high risk of lymph node metastasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Intrahepatic Cholangiocarcinoma Recurrent | Phase 2 | Status: UNKNOWN